Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements.
The woman’s leukemia is in remission and she remains free of detectable HIV more than a year after stopping antiretroviral treatment.
The first two people treated with the “living drug” remained cancer-free for a decade and can be considered cured.
Yes! The Mark Cuban Cost Plus Drug Company sells cheaper generic drugs for diabetes, cancer, high blood pressure, HIV, hepatitis and more.
Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.
Studies point to strategies to reduce disparities, improve outcomes and support shared decision-making.
A law says any biological materials remaining after diagnostic procedures may be used for research—usually without an individual’s consent.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
A pilot study found children with acute lymphocytic leukemia were more likely to be living in the highest density of oil and gas areas.
Could these everyday skin problems be a symptom of an underlying health condition?
Rikako Ikee, who competed in the 2016 Olympics at age 16, was diagnosed with leukemia in early 2019, prompting a yearlong hiatus.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.